Central Nervous System (CNS) Drugs Market Research Report, Growth & Forecast

Publications found: 385

Sort by:

Neurodegenerative Disease Market Size, Share and Growth Outlook 2026: By Indication, By Drug Class, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neurodegenerative Disease Market size is forecast to increase from $67.27 Billion in 2026 to $119.97 Billion in 2034 at a CAGR of 7.5% between 2026 and 2034. The Neurodegenerative Disease m...

July 2026 190 pages

Neuropathic Pain Market Size, Share and Growth Outlook 2026: By Drug Class, By Indication, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neuropathic Pain Market size is forecast to increase from $8.76 Billion in 2026 to $13.75 Billion in 2034 at a CAGR of 5.8% between 2026 and 2034. The Neuropathic Pain market report provide...

July 2026 190 pages

Pregabalin Market Size, Share and Growth Outlook 2026: By Dosage Form (Oral Capsule, Oral Solution, Oral Tablet, Extended Release), By Application, By Drug Class, By Distribution Channel, By End User, Companies to 2034.

US$ 3,482.00

The global Pregabalin Market size is forecast to increase from $1.56 Billion in 2026 to $2.18 Billion in 2034 at a CAGR of 4.3% between 2026 and 2034. The Pregabalin market report provides detailed an...

July 2026 190 pages

Rare Neurological Disease Treatment Market Size, Share and Growth Outlook 2026: By Therapy, By Indication, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Rare Neurological Disease Treatment Market size is forecast to increase from $25.49 Billion in 2026 to $64.94 Billion in 2034 at a CAGR of 12.4% between 2026 and 2034. The Rare Neurological...

July 2026 190 pages

Seasonal Affective Disorder Therapeutics Market Size, Share and Growth Outlook 2026: By Mode of Therapy, By Disorder Type, By Seasonal Pattern, By End-User, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Seasonal Affective Disorder Therapeutics Market size is forecast to increase from $1.11 Billion in 2026 to $1.63 Billion in 2034 at a CAGR of 4.9% between 2026 and 2034. The Seasonal Affect...

July 2026 190 pages

Skin Tears Treatment Market Size, Share and Growth Outlook 2026: By Product Type, By End-User, Companies to 2034

US$ 3,482.00

The global Skin Tears Treatment Market size is forecast to increase from $543.45 Million in 2026 to $892.67 Million in 2034 at a CAGR of 6.4% between 2026 and 2034. The Skin Tears Treatment market rep...

July 2026 190 pages

Substance Abuse Treatment Market Size, Share and Growth Outlook 2026: By Addiction, By Treatment Type, By Care Setting, By Distribution Channel, By End-User, Companies to 2034

US$ 3,482.00

The global Substance Abuse Treatment Market size is forecast to increase from $122.94 Billion in 2026 to $206.23 Billion in 2034 at a CAGR of 6.68% between 2026 and 2034. The Substance Abuse Treatment...

July 2026 190 pages

Tardive Dyskinesia (TD) Treatment Market Size, Share and Growth Outlook 2026: By Drug (Valbenazine (Ingrezza), Deutetrabenazine (Austedo), Tetrabenazine, Other Off-Label Therapeutics), By Indication, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Tardive Dyskinesia (TD) Treatment Market size is forecast to increase from $2.82 Billion in 2026 to $4.1 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034. The Tardive Dyskinesia Trea...

July 2026 190 pages

Tourette Syndrome Treatment Market Size, Share and Growth Outlook 2026: By Treatment (Pharmacotherapy, Non-Pharmacological Therapies), By Route of Administration, By Patient Age Group, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Tourette Syndrome Treatment Market size is forecast to increase from $2.62 Billion in 2026 to $4.43 Billion in 2034 at a CAGR of 6.79% between 2026 and 2034. The Tourette Syndrome Treatment...

July 2026 190 pages

Obsessive-Compulsive Disorder (OCD) Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Severity, By Obsession, By Patient Population, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Obsessive-Compulsive Disorder (OCD) Drugs Market size is forecast to increase from $1.65 Billion in 2026 to $3.64 Billion in 2034 at a CAGR of 10.4% between 2026 and 2034. The Obsessive-Com...

July 2026 190 pages

Insomnia Therapeutics Market Size, Share and Growth Outlook 2026: By Treatment Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Receptor Antagonists, Melatonin Antagonists, Other Therapeutics), By Sales, Companies to 2034

US$ 3,482.00

The global Insomnia Therapeutics Market size is forecast to increase from $3.34 Billion in 2026 to $4.8 Billion in 2034 at a CAGR of 4.64% between 2026 and 2034. The Insomnia Therapeutics market repor...

July 2026 190 pages

Migraine Drugs Market Size, Share and Growth Outlook 2026: By Treatment Type, By Therapeutic Class, By Route of Administration, By Age Group, By Availability, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Migraine Drugs Market size is forecast to increase from $8.26 Billion in 2026 to $16.96 Billion in 2034 at a CAGR of 9.41% between 2026 and 2034. The Migraine Drugs market report provides d...

July 2026 190 pages

Multi-infarct Dementia Market Size, Share and Growth Outlook 2026: By Treatment Type (Pharmacological Therapeutics, Non-Pharmacological Interventions), By Drug Class, By Diagnostics and Assessment, By End-User, Companies to 2034.

US$ 3,482.00

The global Multi-infarct Dementia Market size is forecast to increase from $2.24 Billion in 2026 to $3.01 Billion in 2034 at a CAGR of 3.76% between 2026 and 2034. The Multi-infarct Dementia market re...

July 2026 190 pages

Neuralgia Treatment Market Size, Share and Growth Outlook 2026: By Treatment Type (Medications, Surgical Procedures, Non-Invasive Therapies), By Application, By End-User, Companies to 2034.

US$ 3,482.00

The global Neuralgia Treatment Market size is forecast to increase from $2.32 Billion in 2026 to $3.95 Billion in 2034 at a CAGR of 6.89% between 2026 and 2034. The Neuralgia Treatment market report p...

July 2026 190 pages

Neurometabolic Disorders Market Size, Share and Growth Outlook 2026: By Disorder Type, By Treatment, By Route of Administration, By End-User, Companies to 2034

US$ 3,482.00

The global Neurometabolic Disorders Market size is forecast to increase from $8.95 Billion in 2026 to $16.21 Billion in 2034 at a CAGR of 7.71% between 2026 and 2034. The Neurometabolic Disorders mark...

July 2026 190 pages

Psychedelic Drugs Market Size, Share and Growth Outlook 2026: By Drug Type, By Source, By Application, By Route of Administration, By End-use Setting, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Psychedelic Drugs Market size is forecast to increase from $3.23 Billion in 2026 to $9.4 Billion in 2034 at a CAGR of 14.28% between 2026 and 2034. The Psychedelic Drugs market report provi...

July 2026 190 pages

Schizoaffective Disorders Treatment Market Size, Share and Growth Outlook 2026: By Therapeutic Class, By Route of Administration, By Distribution Channel, By End User, Companies to 2034

US$ 3,482.00

The global Schizoaffective Disorders Treatment Market size is forecast to increase from $5.04 Billion in 2026 to $7.85 Billion in 2034 at a CAGR of 5.69% between 2026 and 2034. The Schizoaffective Dis...

July 2026 190 pages

Spinal Muscular Atrophy Therapeutics Market Size, Share and Growth Outlook 2026: By Disease Type (Type I, Type II, Type III, Type IV), By Drug Type, By Route of Administration, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Spinal Muscular Atrophy Therapeutics Market size is forecast to increase from $5.49 Billion in 2026 to $20.08 Billion in 2034 at a CAGR of 17.6% between 2026 and 2034. The Spinal Muscular A...

July 2026 190 pages

Infantile Spasms Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Category, By Mechanism of Action, By Route of Administration, By Etiology, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Infantile Spasms Therapeutics Market size is forecast to increase from $4.25 Billion in 2026 to $5.73 Billion in 2034 at a CAGR of 3.8% between 2026 and 2034. The Infantile Spasms Therapeut...

July 2026 190 pages

Lennox-Gastaut Syndrome (LGS) Treatment Market Size, Share and Growth Outlook 2026: By Drug, By Route of Administration, By Therapeutic Use, By Age Cohort, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Lennox-Gastaut Syndrome (LGS) Treatment Market size is forecast to increase from $3.54 Billion in 2026 to $5 Billion in 2034 at a CAGR of 4.4% between 2026 and 2034. The Lennox-Gastaut Synd...

July 2026 190 pages

Multiple Sclerosis Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Route of Administration, By Disease Focus, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Multiple Sclerosis Drugs Market size is forecast to increase from $30.89 Billion in 2026 to $49.61 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034. The Multiple Sclerosis Drugs mark...

July 2026 190 pages

Narcolepsy Drugs Market Size, Share and Growth Outlook 2026: By Treatment Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), By Product Type, By End-User, Companies to 2034.

US$ 3,482.00

The global Narcolepsy Drugs Market size is forecast to increase from $4.52 Billion in 2026 to $8.43 Billion in 2034 at a CAGR of 8.1% between 2026 and 2034. The Narcolepsy Drugs market report provides...

July 2026 190 pages

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, Share and Growth Outlook 2026: By Treatment, By Dosage Form, By Diagnosis, By End-User, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market size is forecast to increase from $725.08 Million in 2026 to $1209.05 Million in 2034 at a CAGR of 6.6% between 2026 and 2034. The Neur...

July 2026 190 pages

Pediatric Epilepsy Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Generation, By Disease, By Seizure Type, By Route of Administration, By Distribution Channel, By End-User, Companies to 2034

US$ 3,482.00

The global Pediatric Epilepsy Therapeutics Market size is forecast to increase from $13.9 Billion in 2026 to $22.83 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034. The Pediatric Epilepsy Ther...

July 2026 190 pages

Peripheral Neuropathy Treatment Market Size, Share and Growth Outlook 2026: By Cause, By Treatment Modality, By Drug Class, By Distribution Channel, By End-User, Companies to 2034

US$ 3,482.00

The global Peripheral Neuropathy Treatment Market size is forecast to increase from $2.19 Billion in 2026 to $3.11 Billion in 2034 at a CAGR of 4.5% between 2026 and 2034. The Peripheral Neuropathy Tr...

July 2026 190 pages

Progressive Supranuclear Palsy Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Type, By Phenotype Variant, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Progressive Supranuclear Palsy Therapeutics Market size is forecast to increase from $10.74 Billion in 2026 to $16.61 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034. The Progressiv...

July 2026 190 pages

Restless Legs Syndrome Market Size, Share and Growth Outlook 2026: By Type (Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome), By Treatment Type, Companies to 2034.

US$ 3,482.00

The global Restless Legs Syndrome Market size is forecast to increase from $730.04 Million in 2026 to $983.84 Million in 2034 at a CAGR of 3.8% between 2026 and 2034. The Restless Legs Syndrome market...

July 2026 190 pages

Schizophrenia Therapeutics Market Size, Share and Growth Outlook 2026: By Therapeutic Class (Second-Generation Antipsychotics, Third-Generation Antipsychotics, First-Generation Antipsychotics, Generics), By Treatment Route, Companies to 2034.

US$ 3,482.00

The global Schizophrenia Therapeutics Market size is forecast to increase from $8.94 Billion in 2026 to $13.62 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034. The Schizophrenia Therapeutics m...

July 2026 190 pages

Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Share and Growth Outlook 2026: By Drug Type (Sertraline, Fluoxetine, Escitalopram, Paroxetine, Citalopram, Fluvoxamine), By Indication, By Distribution Channel, Companies to 2034.

US$ 3,482.00

The global Selective Serotonin Reuptake Inhibitors (SSRIs) Market size is forecast to increase from $5.1 Billion in 2026 to $7.09 Billion in 2034 at a CAGR of 4.2% between 2026 and 2034. The Selective...

July 2026 190 pages

Sleep Apnea Implants Market Size, Share and Growth Outlook 2026: By Product, By Indication, By End User, Companies to 2034

US$ 3,482.00

The global Sleep Apnea Implants Market size is forecast to increase from $570.61 Million in 2026 to $1782.27 Million in 2034 at a CAGR of 15.3% between 2026 and 2034. The Sleep Apnea Implants market r...

July 2026 190 pages

Stroke Therapeutics Market Size, Share and Growth Outlook 2026: By Class of Therapeutics, By Stroke Type, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Stroke Therapeutics Market size is forecast to increase from $5.83 Billion in 2026 to $11.03 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034. The Stroke Therapeutics market report p...

July 2026 190 pages

Traumatic Brain Injury Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Class, By Injury Severity Type, By Route of Administration, By End User, Companies to 2034

US$ 3,482.00

The global Traumatic Brain Injury Therapeutics Market size is forecast to increase from $1.86 Billion in 2026 to $4.05 Billion in 2034 at a CAGR of 10.2% between 2026 and 2034. The Traumatic Brain Inj...

July 2026 190 pages

Neurological Disorder Drugs Market Size, Share and Growth Outlook 2026: By Drug Class, By Indication, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neurological Disorder Drugs Market size is forecast to increase from $99.08 Billion in 2026 to $162.75 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034. The Neurological Disorder Dru...

July 2026 190 pages

Neuroprotective Agents Market Size, Share and Growth Outlook 2026: By Drug Class, By Application, By Route of Administration, By End-User, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Neuroprotective Agents Market size is forecast to increase from $28.63 Billion in 2026 to $49.93 Billion in 2034 at a CAGR of 7.2% between 2026 and 2034. The Neuroprotective Agents market r...

July 2026 190 pages

Postpartum Depression Drugs Market Size, Share and Growth Outlook 2026: By Type, By Treatment Type, By Route of Administration, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Postpartum Depression Drugs Market size is forecast to increase from $1.18 Billion in 2026 to $2.49 Billion in 2034 at a CAGR of 9.8% between 2026 and 2034. The Postpartum Depression Drugs...

July 2026 190 pages

Softgel Capsules Market Size, Share and Growth Outlook 2026: By Product Type, By Fill Material, By Application, By Manufacturing Technology, By End-User, Companies to 2034

US$ 3,482.00

The global Softgel Capsules Market size is forecast to increase from $1.49 Billion in 2026 to $2.52 Billion in 2034 at a CAGR of 6.8% between 2026 and 2034. The Softgel Capsules market report provides...

July 2026 190 pages

Parkinson’s Disease Treatment Market Size, Share and Growth Outlook 2026: By Drug Class, By Administration Route, By Distribution Channel, By Patient Care Facility, Companies to 2034

US$ 3,482.00

The global Parkinson’s Disease Treatment Market size is forecast to increase from $6.34 Billion in 2026 to $10.37 Billion in 2034 at a CAGR of 6.34% between 2026 and 2034. The Parkinson’s Disease Trea...

July 2026 190 pages

Post traumatic Stress Disorder Therapeutics Market Size, Share and Growth Outlook 2026: By Drug Class, By Route of Administration, By Demographics, By Distribution Channel, Companies to 2034

US$ 3,482.00

The global Post traumatic Stress Disorder Therapeutics Market size is forecast to increase from $2.6 Billion in 2026 to $3.64 Billion in 2034 at a CAGR of 4.3% between 2026 and 2034. The Post traumati...

July 2026 190 pages

REM Sleep Behavior Disorder Market Size, Share and Growth Outlook 2026: By Type (Idiopathic REM Sleep Behavior Disorder (iRBD), Secondary REM Sleep Behavior Disorder), By Therapy, By Age Group, By End User, Companies to 2034.

US$ 3,482.00

The global REM Sleep Behavior Disorder Market size is forecast to increase from $401.55 Million in 2026 to $658.6 Million in 2034 at a CAGR of 6.38% between 2026 and 2034. The REM Sleep Behavior Disor...

July 2026 190 pages

Treatment-Resistant Depression Market Size, Share and Growth Outlook 2026: By Drug Class, By Distribution Channel, By End-User, Companies to 2034

US$ 3,482.00

The global Treatment-Resistant Depression Market size is forecast to increase from $4.13 Billion in 2026 to $6.63 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034. The Treatment-Resistant Depre...

July 2026 190 pages

Global Cognitive Decline Treatment Market 2026 by Company, Regions, Type and Application, Forecast to 2032

US$ 3,480.00

According to our (Global Info Research) latest study, the global Cognitive Decline Treatment market size was valued at US$ 108585 million in 2025 and is forecast to a readjusted size of US$ 248320 mil...

June 2026 157 pages

Global GABA Receptor Agonists Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

US$ 3,480.00

According to our (Global Info Research) latest study, the global GABA Receptor Agonists market size was valued at US$ 4785 million in 2025 and is forecast to a readjusted size of US$ 7851 million by 2...

June 2026 222 pages

Global Cognitive Decline Treatment Supply, Demand and Key Producers, 2026-2032

US$ 4,480.00

The global Cognitive Decline Treatment market size is expected to reach $ 248320 million by 2032, rising at a market growth of 7.0% CAGR during the forecast period (2026-2032). Cognitive decline treat...

June 2026 152 pages

Global GABA Receptor Agonists Supply, Demand and Key Producers, 2026-2032

US$ 4,480.00

The global GABA Receptor Agonists market size is expected to reach $ 7851 million by 2032, rising at a market growth of 7.2% CAGR during the forecast period (2026-2032). GABA receptor agonists are pre...

June 2026 217 pages

Global Mesylate Safinamide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

US$ 3,480.00

According to our (Global Info Research) latest study, the global Mesylate Safinamide market size was valued at US$ 576 million in 2025 and is forecast to a readjusted size of US$ 1455 million by 2032...

June 2026 103 pages

Global Mesylate Safinamide Supply, Demand and Key Producers, 2026-2032

US$ 4,480.00

The global Mesylate Safinamide market size is expected to reach $ 1455 million by 2032, rising at a market growth of 15.0% CAGR during the forecast period (2026-2032). In 2025, global safinamide mesyl...

June 2026 109 pages

Global Mirogabalin Besilate Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

US$ 3,480.00

According to our (Global Info Research) latest study, the global Mirogabalin Besilate Tablets market size was valued at US$ 504 million in 2025 and is forecast to a readjusted size of US$ 1200 million...

June 2026 70 pages

Global Triptan-Class Migraine Therapeutics Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

US$ 3,480.00

According to our (Global Info Research) latest study, the global Triptan-Class Migraine Therapeutics market size was valued at US$ 1290 million in 2025 and is forecast to a readjusted size of US$ 1574...

June 2026 132 pages

Global Triptan Medications for Migraine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

US$ 3,480.00

According to our (Global Info Research) latest study, the global Triptan Medications for Migraine market size was valued at US$ 1290 million in 2025 and is forecast to a readjusted size of US$ 1574 mi...

June 2026 134 pages

Global Mirogabalin Besilate Tablets Supply, Demand and Key Producers, 2026-2032

US$ 4,480.00

The global Mirogabalin Besilate Tablets market size is expected to reach $ 1200 million by 2032, rising at a market growth of 11.7% CAGR during the forecast period (2026-2032). Mirogabalin Besilate Ta...

June 2026 87 pages